Curaleaf Launches $83M Share Repurchase Program for 5% of Outstanding Shares

summarizeSummary

Curaleaf Holdings, Inc. announced a new share repurchase program, authorizing the buyback of up to $83 million in subordinate voting shares over the next year, representing approximately 5% of its outstanding shares.

check_boxKey Events

• Share Repurchase Program Authorized

  The Board of Directors has authorized a Normal Course Issuer Bid (NCIB) to repurchase up to 34,388,831 subordinate voting shares, representing approximately 5% of the shares outstanding as of April 10, 2026.

• Significant Value of Repurchase

  The aggregate fair market value of the shares authorized for repurchase is approximately U.S.$83 million, based on the closing trading price on April 14, 2026.

• Program Duration and Rationale

  The NCIB will commence on April 20, 2026, and end no later than April 19, 2027. Chairman and CEO Boris Jordan stated the program is a 'meaningful way to return value to our shareholders and reflects our confidence in the strength and durability of our strategy,' indicating management believes the shares may be undervalued.

auto_awesomeAnalysis

Curaleaf Holdings, Inc. has initiated a significant share repurchase program, authorizing the buyback of up to $83 million in subordinate voting shares. This program, representing approximately 5% of the company's outstanding shares, signals strong management confidence in the company's valuation and future strategy. Share repurchases can reduce the number of outstanding shares, potentially boosting earnings per share and supporting the stock price, especially if management believes the shares are undervalued. This move is a direct way to return value to shareholders and could be viewed positively by the market.